Aizawa T, Mamiya Y, Tochimoto M, Ito T, Shiozawa H, Tujino S, Yamamoto S, Miki M, Ishibashi K
Department of Urology, Tokyo Medical College.
Hinyokika Kiyo. 1999 Feb;45(2):111-3.
Three cases of transitional cell carcinoma (TCC) in the urinary bladder diverticulum were encountered during a period of 12 years and bladder preserving treatments were performed. Case 1: A 78-year-old man was admitted with a chief complaint of hematuria. Papillary tumors in the diverticulum of the right bladder wall were revealed (TCC, G3, T3N0M0). Intraarterial infusion chemotherapy was performed and complete remission was achieved. When a recurrent bladder tumor appeared 22 months later, transurethral resection was performed and there was no evidence of recurrence for 50 months. Case 2: A 60-year-old man was admitted with a chief complaint of gross hematuria. Cystoscopic examination revealed papillary tumors in a bladder diverticulum near the ureteral left orifice. Transurethral resection revealed TCC G2 and carcinoma in situ. Partial cystectomy, including the bladder diverticulum, and vesicoureteral neostomy was performed. The histological stage of the tumor was pTis and the wall of diverticulum possessed a thin muscle layer histopathologically. Twenty two months later, recurrence in the left bladder wall developed and transurethral resection and bladder instillation therapy were performed. For 21 months he had no evidence of recurrence. Case 3: A 59-year-old man was admitted with a chief complaint of hematuria. A solid tumor in the diverticulum of the bladder left wall was revealed. After 4 courses of intraarterial infusion chemotherapy, 41% remission was achieved and partial cystectomy was performed. Histopathological diagnosis was TCC G3, pT3b, INF-alpha, v (-), ly (-), and no muscle layer was found in the diverticulum. There was no evidence of recurrence 16 months after operation. By using the combination therapy, bladder preserving treatment is possible in the cases of bladder cancer arising in the diverticulum.
在12年期间共遇到3例膀胱憩室内移行细胞癌(TCC),均采取了保膀胱治疗。病例1:一名78岁男性因血尿为主诉入院。膀胱右壁憩室内发现乳头状肿瘤(TCC,G3,T3N0M0)。进行了动脉内灌注化疗并实现了完全缓解。22个月后出现复发性膀胱肿瘤,行尿道电切术,术后50个月无复发迹象。病例2:一名60岁男性因肉眼血尿为主诉入院。膀胱镜检查发现左侧输尿管口附近膀胱憩室内有乳头状肿瘤。经尿道切除术显示为G2级TCC和原位癌。进行了包括膀胱憩室在内的部分膀胱切除术及膀胱输尿管再植术。肿瘤的组织学分期为pTis,憩室壁在组织病理学上有一层薄肌肉层。22个月后,左膀胱壁复发,进行了经尿道切除术和膀胱灌注治疗。此后21个月无复发迹象。病例3:一名59岁男性因血尿为主诉入院。膀胱左壁憩室内发现实性肿瘤。经过4个疗程的动脉内灌注化疗后,缓解率达到41%,随后进行了部分膀胱切除术。组织病理学诊断为TCC G3,pT3b,INF-α,v(-),ly(-),憩室内未发现肌肉层。术后16个月无复发迹象。通过联合治疗,膀胱憩室来源的膀胱癌病例有可能实现保膀胱治疗。